Cisen Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Chenxin Pharmaceutical Co., Ltd. is currently a listed company on the main board of the Shanghai Stock Exchange (stock abbreviation: Chenxin Pharmaceutical, stock code: 603367). It is a comprehensive pharmaceutical enterprise that integrates research and development, production, and sales, located in Jining City, Shandong Province. The company was established in 1970, formerly known as Jining Third Pharmaceutical Factory. In 1998, it was renamed Shandong Lukang Chenxin Pharmaceutical Co., Ltd. In 2011, it was renamed Chenxin Pharmaceutical Co., Ltd. The company is now the national recognized enterprise technology center, vice president unit of China Chemical Pharmaceutical Industry Association, high-tech enterprise, "contract abiding and trustworthy enterprise" of the State Administration for Industry and Commerce in 2014-2015, with postdoctoral research workstation, Mount Taishan scholar pharmaceutical special expert position in Shandong Province, national and local joint engineering laboratory for intravenous nutrition high-capacity injection Shandong Provincial Antibiotic Engineering Technology Research Center and Shandong Provincial Intravenous Nutrition Large Capacity Injection Engineering Laboratory, and have obtained the National Accreditation Assessment Committee (CNAS) accreditation certificate. Chenxin Pharmaceutical takes ensuring and improving the quality of life and health of patients as its own responsibility, spending 6% of its annual sales revenue on scientific and technological research and development. It is committed to independent research and production of drugs that can fill the domestic gap. We have established long-term cooperative relationships with research institutes such as China Pharmaceutical University, Shanghai Institute of Pharmacy, Chinese Academy of Sciences, Academy of Military Medical Sciences, Shenyang Pharmaceutical University, Shandong University, Shandong Medical Academy, Shandong Institute of Pharmaceutical Industry, and have successfully embarked on a path of "joint innovation of industry, academia, and research". Among them, adefovir dipivoxil (raw materials and tablets) independently developed by Chenxin Pharmaceutical has obtained the National First Class New Drug Certificate, Received the first prize for scientific and technological progress in Shandong Province, and received support from the Ministry of Science and Technology, provincial, and municipal scientific and technological innovation funds. The successful development of this drug is a major breakthrough in the field of independent research and development of hepatitis B drug treatment in China. It is of great significance to promote the technological progress of China's pharmaceutical industry, accelerate the industrialization of China's high-tech achievements in medicine, and improve the technological innovation ability and international competitiveness of China's bio pharmaceutical industry. It will also be the engine for Chenxin brand to improve again. In the future, Chenxin Pharmaceutical will leverage the wings of the capital market to accelerate technological innovation and improve product quality. With excellent product quality and comprehensive and efficient supporting services, it will create value-added returns for customers, shareholders, employees, and society, and repay investors with even better business performance!. |
| Headquarter | Jining |
| Establish Date | 11/6/1998 |
| Listed Code | 603367.SH |
| Listed Date | 9/29/2017 |
| Chairman | Du Zhenxin. |
| CEO | Du Zhenxin. |
| Website | www.cisen-pharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
